img

Global Irinotecan Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Irinotecan Market Insights, Forecast to 2034

Irinotecan is a chemotherapy medication used to treat various types of cancer, including colorectal cancer and lung cancer.
Global Irinotecan market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Irinotecan industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
MarketThe market for irinotecan is driven by its applications in cancer treatment, where it is used to inhibit the growth of cancer cells and improve patient outcomes. It is an essential drug in oncology and is often used in combination with other chemotherapy agents.
Report Covers
This report presents an overview of global Irinotecan market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Irinotecan market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


West-Ward Pharmaceuticals
Pfizer
Teva
Actiza Pharmaceutical
Getwell
Taj Pharma
Cipla
Salius
Segment by Type
Irinotecan Hydrochloride Injection 40mg
Other

Segment by Application


Colon Cancer
Rectal Cancer

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Irinotecan plant distribution, commercial date of Irinotecan, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Irinotecan introduction, etc. Irinotecan Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Irinotecan
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Irinotecan Product Introduction
1.2 Market by Type
1.2.1 Global Irinotecan Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Irinotecan Hydrochloride Injection 40mg
1.2.3 Other
1.3 Market by Application
1.3.1 Global Irinotecan Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Colon Cancer
1.3.3 Rectal Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Irinotecan Sales Estimates and Forecasts 2018-2029
2.2 Global Irinotecan Revenue by Region
2.2.1 Global Irinotecan Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Irinotecan Revenue by Region (2018-2024)
2.2.3 Global Irinotecan Revenue by Region (2024-2029)
2.2.4 Global Irinotecan Revenue Market Share by Region (2018-2029)
2.3 Global Irinotecan Sales Estimates and Forecasts 2018-2029
2.4 Global Irinotecan Sales by Region
2.4.1 Global Irinotecan Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Irinotecan Sales by Region (2018-2024)
2.4.3 Global Irinotecan Sales by Region (2024-2029)
2.4.4 Global Irinotecan Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Irinotecan Sales by Manufacturers
3.1.1 Global Irinotecan Sales by Manufacturers (2018-2024)
3.1.2 Global Irinotecan Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Irinotecan in 2022
3.2 Global Irinotecan Revenue by Manufacturers
3.2.1 Global Irinotecan Revenue by Manufacturers (2018-2024)
3.2.2 Global Irinotecan Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Irinotecan Revenue in 2022
3.3 Global Key Players of Irinotecan, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Irinotecan Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Irinotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Irinotecan, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Irinotecan, Product Offered and Application
3.8 Global Key Manufacturers of Irinotecan, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Irinotecan Sales by Type
4.1.1 Global Irinotecan Historical Sales by Type (2018-2024)
4.1.2 Global Irinotecan Forecasted Sales by Type (2024-2029)
4.1.3 Global Irinotecan Sales Market Share by Type (2018-2029)
4.2 Global Irinotecan Revenue by Type
4.2.1 Global Irinotecan Historical Revenue by Type (2018-2024)
4.2.2 Global Irinotecan Forecasted Revenue by Type (2024-2029)
4.2.3 Global Irinotecan Revenue Market Share by Type (2018-2029)
4.3 Global Irinotecan Price by Type
4.3.1 Global Irinotecan Price by Type (2018-2024)
4.3.2 Global Irinotecan Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Irinotecan Sales by Application
5.1.1 Global Irinotecan Historical Sales by Application (2018-2024)
5.1.2 Global Irinotecan Forecasted Sales by Application (2024-2029)
5.1.3 Global Irinotecan Sales Market Share by Application (2018-2029)
5.2 Global Irinotecan Revenue by Application
5.2.1 Global Irinotecan Historical Revenue by Application (2018-2024)
5.2.2 Global Irinotecan Forecasted Revenue by Application (2024-2029)
5.2.3 Global Irinotecan Revenue Market Share by Application (2018-2029)
5.3 Global Irinotecan Price by Application
5.3.1 Global Irinotecan Price by Application (2018-2024)
5.3.2 Global Irinotecan Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Irinotecan Market Size by Type
6.1.1 US & Canada Irinotecan Sales by Type (2018-2029)
6.1.2 US & Canada Irinotecan Revenue by Type (2018-2029)
6.2 US & Canada Irinotecan Market Size by Application
6.2.1 US & Canada Irinotecan Sales by Application (2018-2029)
6.2.2 US & Canada Irinotecan Revenue by Application (2018-2029)
6.3 US & Canada Irinotecan Market Size by Country
6.3.1 US & Canada Irinotecan Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Irinotecan Sales by Country (2018-2029)
6.3.3 US & Canada Irinotecan Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Irinotecan Market Size by Type
7.1.1 Europe Irinotecan Sales by Type (2018-2029)
7.1.2 Europe Irinotecan Revenue by Type (2018-2029)
7.2 Europe Irinotecan Market Size by Application
7.2.1 Europe Irinotecan Sales by Application (2018-2029)
7.2.2 Europe Irinotecan Revenue by Application (2018-2029)
7.3 Europe Irinotecan Market Size by Country
7.3.1 Europe Irinotecan Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Irinotecan Sales by Country (2018-2029)
7.3.3 Europe Irinotecan Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Irinotecan Market Size
8.1.1 China Irinotecan Sales (2018-2029)
8.1.2 China Irinotecan Revenue (2018-2029)
8.2 China Irinotecan Market Size by Application
8.2.1 China Irinotecan Sales by Application (2018-2029)
8.2.2 China Irinotecan Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Irinotecan Market Size by Type
9.1.1 Asia Irinotecan Sales by Type (2018-2029)
9.1.2 Asia Irinotecan Revenue by Type (2018-2029)
9.2 Asia Irinotecan Market Size by Application
9.2.1 Asia Irinotecan Sales by Application (2018-2029)
9.2.2 Asia Irinotecan Revenue by Application (2018-2029)
9.3 Asia Irinotecan Sales by Region
9.3.1 Asia Irinotecan Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Irinotecan Revenue by Region (2018-2029)
9.3.3 Asia Irinotecan Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Irinotecan Market Size by Type
10.1.1 Middle East, Africa and Latin America Irinotecan Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Irinotecan Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Irinotecan Market Size by Application
10.2.1 Middle East, Africa and Latin America Irinotecan Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Irinotecan Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Irinotecan Sales by Country
10.3.1 Middle East, Africa and Latin America Irinotecan Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Irinotecan Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Irinotecan Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 West-Ward Pharmaceuticals
11.1.1 West-Ward Pharmaceuticals Company Information
11.1.2 West-Ward Pharmaceuticals Overview
11.1.3 West-Ward Pharmaceuticals Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 West-Ward Pharmaceuticals Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 West-Ward Pharmaceuticals Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Pfizer Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Teva
11.3.1 Teva Company Information
11.3.2 Teva Overview
11.3.3 Teva Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Teva Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Recent Developments
11.4 Actiza Pharmaceutical
11.4.1 Actiza Pharmaceutical Company Information
11.4.2 Actiza Pharmaceutical Overview
11.4.3 Actiza Pharmaceutical Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Actiza Pharmaceutical Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Actiza Pharmaceutical Recent Developments
11.5 Getwell
11.5.1 Getwell Company Information
11.5.2 Getwell Overview
11.5.3 Getwell Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Getwell Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Getwell Recent Developments
11.6 Taj Pharma
11.6.1 Taj Pharma Company Information
11.6.2 Taj Pharma Overview
11.6.3 Taj Pharma Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Taj Pharma Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Taj Pharma Recent Developments
11.7 Cipla
11.7.1 Cipla Company Information
11.7.2 Cipla Overview
11.7.3 Cipla Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Cipla Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cipla Recent Developments
11.8 Salius
11.8.1 Salius Company Information
11.8.2 Salius Overview
11.8.3 Salius Irinotecan Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Salius Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Salius Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Irinotecan Industry Chain Analysis
12.2 Irinotecan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Irinotecan Production Mode & Process
12.4 Irinotecan Sales and Marketing
12.4.1 Irinotecan Sales Channels
12.4.2 Irinotecan Distributors
12.5 Irinotecan Customers
13 Market Dynamics
13.1 Irinotecan Industry Trends
13.2 Irinotecan Market Drivers
13.3 Irinotecan Market Challenges
13.4 Irinotecan Market Restraints
14 Key Findings in The Global Irinotecan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Irinotecan Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Irinotecan Hydrochloride Injection 40mg
Table 3. Major Manufacturers of Other
Table 4. Global Irinotecan Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Irinotecan Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Irinotecan Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Irinotecan Revenue Market Share by Region (2018-2024)
Table 9. Global Irinotecan Revenue Market Share by Region (2024-2029)
Table 10. Global Irinotecan Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Irinotecan Sales by Region (2018-2024) & (MT)
Table 12. Global Irinotecan Sales by Region (2024-2029) & (MT)
Table 13. Global Irinotecan Sales Market Share by Region (2018-2024)
Table 14. Global Irinotecan Sales Market Share by Region (2024-2029)
Table 15. Global Irinotecan Sales by Manufacturers (2018-2024) & (MT)
Table 16. Global Irinotecan Sales Share by Manufacturers (2018-2024)
Table 17. Global Irinotecan Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Irinotecan Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Irinotecan, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Irinotecan Price by Manufacturers 2018-2024 (USD/Kg)
Table 21. Global Irinotecan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Irinotecan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irinotecan as of 2022)
Table 23. Global Key Manufacturers of Irinotecan, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Irinotecan, Product Offered and Application
Table 25. Global Key Manufacturers of Irinotecan, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Irinotecan Sales by Type (2018-2024) & (MT)
Table 28. Global Irinotecan Sales by Type (2024-2029) & (MT)
Table 29. Global Irinotecan Sales Share by Type (2018-2024)
Table 30. Global Irinotecan Sales Share by Type (2024-2029)
Table 31. Global Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Irinotecan Revenue Share by Type (2018-2024)
Table 34. Global Irinotecan Revenue Share by Type (2024-2029)
Table 35. Irinotecan Price by Type (2018-2024) & (USD/Kg)
Table 36. Global Irinotecan Price Forecast by Type (2024-2029) & (USD/Kg)
Table 37. Global Irinotecan Sales by Application (2018-2024) & (MT)
Table 38. Global Irinotecan Sales by Application (2024-2029) & (MT)
Table 39. Global Irinotecan Sales Share by Application (2018-2024)
Table 40. Global Irinotecan Sales Share by Application (2024-2029)
Table 41. Global Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Irinotecan Revenue Share by Application (2018-2024)
Table 44. Global Irinotecan Revenue Share by Application (2024-2029)
Table 45. Irinotecan Price by Application (2018-2024) & (USD/Kg)
Table 46. Global Irinotecan Price Forecast by Application (2024-2029) & (USD/Kg)
Table 47. US & Canada Irinotecan Sales by Type (2018-2024) & (MT)
Table 48. US & Canada Irinotecan Sales by Type (2024-2029) & (MT)
Table 49. US & Canada Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Irinotecan Sales by Application (2018-2024) & (MT)
Table 52. US & Canada Irinotecan Sales by Application (2024-2029) & (MT)
Table 53. US & Canada Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Irinotecan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Irinotecan Sales by Country (2018-2024) & (MT)
Table 59. US & Canada Irinotecan Sales by Country (2024-2029) & (MT)
Table 60. Europe Irinotecan Sales by Type (2018-2024) & (MT)
Table 61. Europe Irinotecan Sales by Type (2024-2029) & (MT)
Table 62. Europe Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Irinotecan Sales by Application (2018-2024) & (MT)
Table 65. Europe Irinotecan Sales by Application (2024-2029) & (MT)
Table 66. Europe Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Irinotecan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Irinotecan Sales by Country (2018-2024) & (MT)
Table 72. Europe Irinotecan Sales by Country (2024-2029) & (MT)
Table 73. China Irinotecan Sales by Type (2018-2024) & (MT)
Table 74. China Irinotecan Sales by Type (2024-2029) & (MT)
Table 75. China Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Irinotecan Sales by Application (2018-2024) & (MT)
Table 78. China Irinotecan Sales by Application (2024-2029) & (MT)
Table 79. China Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Irinotecan Sales by Type (2018-2024) & (MT)
Table 82. Asia Irinotecan Sales by Type (2024-2029) & (MT)
Table 83. Asia Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Irinotecan Sales by Application (2018-2024) & (MT)
Table 86. Asia Irinotecan Sales by Application (2024-2029) & (MT)
Table 87. Asia Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Irinotecan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Irinotecan Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Irinotecan Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Irinotecan Sales by Region (2018-2024) & (MT)
Table 93. Asia Irinotecan Sales by Region (2024-2029) & (MT)
Table 94. Middle East, Africa and Latin America Irinotecan Sales by Type (2018-2024) & (MT)
Table 95. Middle East, Africa and Latin America Irinotecan Sales by Type (2024-2029) & (MT)
Table 96. Middle East, Africa and Latin America Irinotecan Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Irinotecan Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Irinotecan Sales by Application (2018-2024) & (MT)
Table 99. Middle East, Africa and Latin America Irinotecan Sales by Application (2024-2029) & (MT)
Table 100. Middle East, Africa and Latin America Irinotecan Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Irinotecan Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Irinotecan Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Irinotecan Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Irinotecan Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Irinotecan Sales by Country (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Irinotecan Sales by Country (2024-2029) & (MT)
Table 107. West-Ward Pharmaceuticals Company Information
Table 108. West-Ward Pharmaceuticals Description and Major Businesses
Table 109. West-Ward Pharmaceuticals Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 110. West-Ward Pharmaceuticals Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. West-Ward Pharmaceuticals Recent Developments
Table 112. Pfizer Company Information
Table 113. Pfizer Description and Major Businesses
Table 114. Pfizer Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 115. Pfizer Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer Recent Developments
Table 117. Teva Company Information
Table 118. Teva Description and Major Businesses
Table 119. Teva Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 120. Teva Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Recent Developments
Table 122. Actiza Pharmaceutical Company Information
Table 123. Actiza Pharmaceutical Description and Major Businesses
Table 124. Actiza Pharmaceutical Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 125. Actiza Pharmaceutical Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Actiza Pharmaceutical Recent Developments
Table 127. Getwell Company Information
Table 128. Getwell Description and Major Businesses
Table 129. Getwell Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 130. Getwell Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Getwell Recent Developments
Table 132. Taj Pharma Company Information
Table 133. Taj Pharma Description and Major Businesses
Table 134. Taj Pharma Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 135. Taj Pharma Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Taj Pharma Recent Developments
Table 137. Cipla Company Information
Table 138. Cipla Description and Major Businesses
Table 139. Cipla Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 140. Cipla Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Cipla Recent Developments
Table 142. Salius Company Information
Table 143. Salius Description and Major Businesses
Table 144. Salius Irinotecan Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 145. Salius Irinotecan Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Salius Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Irinotecan Distributors List
Table 150. Irinotecan Customers List
Table 151. Irinotecan Market Trends
Table 152. Irinotecan Market Drivers
Table 153. Irinotecan Market Challenges
Table 154. Irinotecan Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Irinotecan Product Picture
Figure 2. Global Irinotecan Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Irinotecan Market Share by Type in 2022 & 2029
Figure 4. Irinotecan Hydrochloride Injection 40mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Irinotecan Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Irinotecan Market Share by Application in 2022 & 2029
Figure 8. Colon Cancer
Figure 9. Rectal Cancer
Figure 10. Irinotecan Report Years Considered
Figure 11. Global Irinotecan Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Irinotecan Revenue 2018-2029 (US$ Million)
Figure 13. Global Irinotecan Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Irinotecan Revenue Market Share by Region (2018-2029)
Figure 15. Global Irinotecan Sales 2018-2029 ((MT)
Figure 16. Global Irinotecan Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Irinotecan Sales YoY (2018-2029) & (MT)
Figure 18. US & Canada Irinotecan Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Irinotecan Sales YoY (2018-2029) & (MT)
Figure 20. Europe Irinotecan Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Irinotecan Sales YoY (2018-2029) & (MT)
Figure 22. China Irinotecan Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Irinotecan Sales YoY (2018-2029) & (MT)
Figure 24. Asia (excluding China) Irinotecan Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Irinotecan Sales YoY (2018-2029) & (MT)
Figure 26. Middle East, Africa and Latin America Irinotecan Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Irinotecan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Irinotecan in the World: Market Share by Irinotecan Revenue in 2022
Figure 29. Global Irinotecan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Irinotecan Sales Market Share by Type (2018-2029)
Figure 31. Global Irinotecan Revenue Market Share by Type (2018-2029)
Figure 32. Global Irinotecan Sales Market Share by Application (2018-2029)
Figure 33. Global Irinotecan Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Irinotecan Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Irinotecan Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Irinotecan Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Irinotecan Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Irinotecan Revenue Share by Country (2018-2029)
Figure 39. US & Canada Irinotecan Sales Share by Country (2018-2029)
Figure 40. U.S. Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Irinotecan Sales Market Share by Type (2018-2029)
Figure 43. Europe Irinotecan Revenue Market Share by Type (2018-2029)
Figure 44. Europe Irinotecan Sales Market Share by Application (2018-2029)
Figure 45. Europe Irinotecan Revenue Market Share by Application (2018-2029)
Figure 46. Europe Irinotecan Revenue Share by Country (2018-2029)
Figure 47. Europe Irinotecan Sales Share by Country (2018-2029)
Figure 48. Germany Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 49. France Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 53. China Irinotecan Sales Market Share by Type (2018-2029)
Figure 54. China Irinotecan Revenue Market Share by Type (2018-2029)
Figure 55. China Irinotecan Sales Market Share by Application (2018-2029)
Figure 56. China Irinotecan Revenue Market Share by Application (2018-2029)
Figure 57. Asia Irinotecan Sales Market Share by Type (2018-2029)
Figure 58. Asia Irinotecan Revenue Market Share by Type (2018-2029)
Figure 59. Asia Irinotecan Sales Market Share by Application (2018-2029)
Figure 60. Asia Irinotecan Revenue Market Share by Application (2018-2029)
Figure 61. Asia Irinotecan Revenue Share by Region (2018-2029)
Figure 62. Asia Irinotecan Sales Share by Region (2018-2029)
Figure 63. Japan Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 67. India Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Irinotecan Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Irinotecan Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Irinotecan Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Irinotecan Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Irinotecan Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Irinotecan Sales Share by Country (2018-2029)
Figure 74. Brazil Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Irinotecan Revenue (2018-2029) & (US$ Million)
Figure 79. Irinotecan Value Chain
Figure 80. Irinotecan Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed